Scancell Holdings plc (SCLP) Ord GBP0.001

Sell:10.50pBuy:11.50pNo change

Prices delayed by at least 15 minutes
Sell:10.50p
Buy:11.50p
Change:No change
Deal now
Prices delayed by at least 15 minutes
Sell:10.50p
Buy:11.50p
Change:No change
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Scancell Holdings plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is a developer of immunotherapies for the treatment of cancer and infectious diseases. The Company is building a pipeline of products by utilizing its four technology platforms: Moditope and ImmunoBody for vaccines and GlyMab and AvidiMab for antibodies. Its product pipeline includes Modi-1, Modi-2, SCIB1 & iSCIB1+, SCIB2 & iSCIB2, SCOV1 and SCOV2 (COVIDITY), as well as Anti-glycan antibodies. Modi-1, which targets citrullinated cancer antigens, is the first therapeutic vaccine candidate to emerge from Scancell's Moditope platform. Modi-2, which targets homocitrullinated cancer antigens, is the second therapeutic vaccine candidate from the Company's Moditope platform. Its lead ImmunoBody cancer vaccine, SCIB1, is being developed for the treatment of patients with metastatic melanoma. The COVIDITY program, focuses on the Company's COVID-19 vaccine candidates, SCOV1 and SCOV2.

Key people

Phil L'huillier
Chief Executive Officer, Executive Director
Sathijeevan Nirmalananthan
Chief Financial Officer, Executive Director
Lindy Gillian Durrant
Chief Scientific Officer, Executive Director
Callum Scott
Head of Development
Nermeen Varawalla
Chief Medical Officer
Jean-Michel Yves Sylvain Cossery
Non-Executive Chairman of the Board
Martin Diggle
Non-Executive Director
Florian N. Reinaud
Non-Executive Director
Susan Clement-Davies
Non-Executive Independent Director
Ursula M. Ney
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    SCLP
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00B63D3314
  • Market cap
    £114.16m
  • Employees
    61
  • Shares in issue
    1.04bn
  • Exchange
    London Stock Exchange (LON)
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.